Literature DB >> 26018159

Vaccine-Induced Linear Epitope-Specific Antibodies to Simian Immunodeficiency Virus SIVmac239 Envelope Are Distinct from Those Induced to the Human Immunodeficiency Virus Type 1 Envelope in Nonhuman Primates.

Xiaoying Shen1, Ryan Duffy2, Robert Howington2, Alethea Cope3, Shanmugalakshmi Sadagopal4, Haesun Park5, Ranajit Pal6, Suefen Kwa4, Song Ding7, Otto O Yang8, Genevieve G Fouda9, Roger Le Grand10, Diane Bolton11, Mariano Esteban12, Sanjay Phogat13, Mario Roederer11, Rama R Amara4, Louis J Picker5, Robert A Seder11, M Juliana McElrath14, Susan Barnett15, Sallie R Permar16, Robin Shattock3, Anthony L DeVico17, Barbara K Felber18, George N Pavlakis19, Giuseppe Pantaleo7, Bette T Korber20, David C Montefiori21, Georgia D Tomaras22.   

Abstract

To evaluate antibody specificities induced by simian immunodeficiency virus (SIV) versus human immunodeficiency virus type 1 (HIV-1) envelope antigens in nonhuman primate (NHP), we profiled binding antibody responses to linear epitopes in NHP studies with HIV-1 or SIV immunogens. We found that, overall, HIV-1 Env IgG responses were dominated by V3, with the notable exception of the responses to the vaccine strain A244 Env that were dominated by V2, whereas the anti-SIVmac239 Env responses were dominated by V2 regardless of the vaccine regimen.
Copyright © 2015, American Society for Microbiology. All Rights Reserved.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26018159      PMCID: PMC4524233          DOI: 10.1128/JVI.03635-14

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  41 in total

1.  Selective induction of host genes by MVA-B, a candidate vaccine against HIV/AIDS.

Authors:  Susana Guerra; José Manuel González; Núria Climent; Hugh Reyburn; Luis A López-Fernández; José L Nájera; Carmen E Gómez; Felipe García; José M Gatell; Teresa Gallart; Mariano Esteban
Journal:  J Virol       Date:  2010-06-09       Impact factor: 5.103

2.  HIV envelope induces a cascade of cell signals in non-proliferating target cells that favor virus replication.

Authors:  Claudia Cicala; James Arthos; Sara M Selig; Glynn Dennis; Douglas A Hosack; Donald Van Ryk; Marion L Spangler; Tavis D Steenbeke; Prateeti Khazanie; Neil Gupta; Jun Yang; Marybeth Daucher; Richard A Lempicki; Anthony S Fauci
Journal:  Proc Natl Acad Sci U S A       Date:  2002-06-27       Impact factor: 11.205

3.  CD40L-adjuvanted DNA/modified vaccinia virus Ankara simian immunodeficiency virus (SIV) vaccine enhances protection against neutralization-resistant mucosal SIV infection.

Authors:  Suefen Kwa; Shanmugalakshmi Sadagopal; Xiaoying Shen; Jung Joo Hong; Sailaja Gangadhara; Rahul Basu; Blandine Victor; Smita S Iyer; Celia C LaBranche; David C Montefiori; Georgia D Tomaras; Francois Villinger; Bernard Moss; Pamela A Kozlowski; Rama Rao Amara
Journal:  J Virol       Date:  2015-02-04       Impact factor: 5.103

4.  Polyfunctional Fc-effector profiles mediated by IgG subclass selection distinguish RV144 and VAX003 vaccines.

Authors:  Amy W Chung; Musie Ghebremichael; Hannah Robinson; Eric Brown; Ickwon Choi; Sophie Lane; Anne-Sophie Dugast; Matthew K Schoen; Morgane Rolland; Todd J Suscovich; Alison E Mahan; Larry Liao; Hendrik Streeck; Charla Andrews; Supachai Rerks-Ngarm; Sorachai Nitayaphan; Mark S de Souza; Jaranit Kaewkungwal; Punnee Pitisuttithum; Donald Francis; Nelson L Michael; Jerome H Kim; Chris Bailey-Kellogg; Margaret E Ackerman; Galit Alter
Journal:  Sci Transl Med       Date:  2014-03-19       Impact factor: 17.956

5.  Vaccine-induced Env V1-V2 IgG3 correlates with lower HIV-1 infection risk and declines soon after vaccination.

Authors:  Nicole L Yates; Hua-Xin Liao; Youyi Fong; Allan deCamp; Nathan A Vandergrift; William T Williams; S Munir Alam; Guido Ferrari; Zhi-yong Yang; Kelly E Seaton; Phillip W Berman; Michael D Alpert; David T Evans; Robert J O'Connell; Donald Francis; Faruk Sinangil; Carter Lee; Sorachai Nitayaphan; Supachai Rerks-Ngarm; Jaranit Kaewkungwal; Punnee Pitisuttithum; James Tartaglia; Abraham Pinter; Susan Zolla-Pazner; Peter B Gilbert; Gary J Nabel; Nelson L Michael; Jerome H Kim; David C Montefiori; Barton F Haynes; Georgia D Tomaras
Journal:  Sci Transl Med       Date:  2014-03-19       Impact factor: 17.956

6.  Isolation of HIV-1-neutralizing mucosal monoclonal antibodies from human colostrum.

Authors:  James Friedman; S Munir Alam; Xiaoying Shen; Shi-Mao Xia; Shelley Stewart; Kara Anasti; Justin Pollara; Genevieve G Fouda; Guang Yang; Garnett Kelsoe; Guido Ferrari; Georgia D Tomaras; Barton F Haynes; Hua-Xin Liao; M Anthony Moody; Sallie R Permar
Journal:  PLoS One       Date:  2012-05-18       Impact factor: 3.240

7.  Vaccination against heterologous R5 clade C SHIV: prevention of infection and correlates of protection.

Authors:  Samir K Lakhashe; Wendy Wang; Nagadenahalli B Siddappa; Girish Hemashettar; Patricia Polacino; Shiu-Lok Hu; François Villinger; James G Else; Francis J Novembre; John K Yoon; Sandra J Lee; David C Montefiori; Ruth M Ruprecht; Robert A Rasmussen
Journal:  PLoS One       Date:  2011-07-20       Impact factor: 3.240

8.  Vaccine-induced Human Antibodies Specific for the Third Variable Region of HIV-1 gp120 Impose Immune Pressure on Infecting Viruses.

Authors:  Susan Zolla-Pazner; Paul T Edlefsen; Morgane Rolland; Xiang-Peng Kong; Allan deCamp; Raphael Gottardo; Constance Williams; Sodsai Tovanabutra; Sandra Sharpe-Cohen; James I Mullins; Mark S deSouza; Nicos Karasavvas; Sorachai Nitayaphan; Supachai Rerks-Ngarm; Punnee Pitisuttihum; Jaranit Kaewkungwal; Robert J O'Connell; Merlin L Robb; Nelson L Michael; Jerome H Kim; Peter Gilbert
Journal:  EBioMedicine       Date:  2014-11-01       Impact factor: 8.143

9.  Analysis of V2 antibody responses induced in vaccinees in the ALVAC/AIDSVAX HIV-1 vaccine efficacy trial.

Authors:  Susan Zolla-Pazner; Allan C deCamp; Timothy Cardozo; Nicos Karasavvas; Raphael Gottardo; Constance Williams; Daryl E Morris; Georgia Tomaras; Mangala Rao; Erik Billings; Phillip Berman; Xiaoying Shen; Charla Andrews; Robert J O'Connell; Viseth Ngauy; Sorachai Nitayaphan; Mark de Souza; Bette Korber; Richard Koup; Robert T Bailer; John R Mascola; Abraham Pinter; David Montefiori; Barton F Haynes; Merlin L Robb; Supachai Rerks-Ngarm; Nelson L Michael; Peter B Gilbert; Jerome H Kim
Journal:  PLoS One       Date:  2013-01-17       Impact factor: 3.240

10.  Plasma IgG to linear epitopes in the V2 and V3 regions of HIV-1 gp120 correlate with a reduced risk of infection in the RV144 vaccine efficacy trial.

Authors:  Raphael Gottardo; Robert T Bailer; Bette T Korber; S Gnanakaran; Joshua Phillips; Xiaoying Shen; Georgia D Tomaras; Ellen Turk; Gregory Imholte; Larry Eckler; Holger Wenschuh; Johannes Zerweck; Kelli Greene; Hongmei Gao; Phillip W Berman; Donald Francis; Faruk Sinangil; Carter Lee; Sorachai Nitayaphan; Supachai Rerks-Ngarm; Jaranit Kaewkungwal; Punnee Pitisuttithum; James Tartaglia; Merlin L Robb; Nelson L Michael; Jerome H Kim; Susan Zolla-Pazner; Barton F Haynes; John R Mascola; Steve Self; Peter Gilbert; David C Montefiori
Journal:  PLoS One       Date:  2013-09-26       Impact factor: 3.240

View more
  37 in total

1.  Immune correlates of the Thai RV144 HIV vaccine regimen in South Africa.

Authors:  Glenda E Gray; Ying Huang; Nicole Grunenberg; Fatima Laher; Surita Roux; Erica Andersen-Nissen; Stephen C De Rosa; Britta Flach; April K Randhawa; Ryan Jensen; Edith M Swann; Linda-Gail Bekker; Craig Innes; Erica Lazarus; Lynn Morris; Nonhlanhla N Mkhize; Guido Ferrari; David C Montefiori; Xiaoying Shen; Sheetal Sawant; Nicole Yates; John Hural; Abby Isaacs; Sanjay Phogat; Carlos A DiazGranados; Carter Lee; Faruk Sinangil; Nelson L Michael; Merlin L Robb; James G Kublin; Peter B Gilbert; M Juliana McElrath; Georgia D Tomaras; Lawrence Corey
Journal:  Sci Transl Med       Date:  2019-09-18       Impact factor: 17.956

Review 2.  Complex immune correlates of protection in HIV-1 vaccine efficacy trials.

Authors:  Georgia D Tomaras; Stanley A Plotkin
Journal:  Immunol Rev       Date:  2017-01       Impact factor: 12.988

3.  Impact of Poxvirus Vector Priming, Protein Coadministration, and Vaccine Intervals on HIV gp120 Vaccine-Elicited Antibody Magnitude and Function in Infant Macaques.

Authors:  Bonnie Phillips; Genevieve G Fouda; Josh Eudailey; Justin Pollara; Alan D Curtis; Erika Kunz; Maria Dennis; Xiaoying Shen; Camden Bay; Michael Hudgens; David Pickup; S Munir Alam; Amir Ardeshir; Pamela A Kozlowski; Koen K A Van Rompay; Guido Ferrari; M Anthony Moody; Sallie Permar; Kristina De Paris
Journal:  Clin Vaccine Immunol       Date:  2017-10-05

4.  Immunodominance of Antibody Recognition of the HIV Envelope V2 Region in Ig-Humanized Mice.

Authors:  Kevin Wiehe; Nathan I Nicely; Bradley Lockwood; Masayuki Kuraoka; Kara Anasti; Sabrina Arora; Cindy M Bowman; Christina Stolarchuk; Robert Parks; Krissey E Lloyd; Shi-Mao Xia; Ryan Duffy; Xiaoying Shen; Christos A Kyratsous; Lynn E Macdonald; Andrew J Murphy; Richard M Scearce; M Anthony Moody; S Munir Alam; Laurent Verkoczy; Georgia D Tomaras; Garnett Kelsoe; Barton F Haynes
Journal:  J Immunol       Date:  2016-12-23       Impact factor: 5.422

5.  Coadministration of CH31 Broadly Neutralizing Antibody Does Not Affect Development of Vaccine-Induced Anti-HIV-1 Envelope Antibody Responses in Infant Rhesus Macaques.

Authors:  Maria Dennis; Joshua Eudailey; Justin Pollara; Arthur S McMillan; Kenneth D Cronin; Pooja T Saha; Alan D Curtis; Michael G Hudgens; Genevieve G Fouda; Guido Ferrari; Munir Alam; Koen K A Van Rompay; Kristina De Paris; Sallie Permar; Xiaoying Shen
Journal:  J Virol       Date:  2019-02-19       Impact factor: 5.103

6.  Simian-Human Immunodeficiency Virus SHIV.CH505-Infected Infant and Adult Rhesus Macaques Exhibit Similar Env-Specific Antibody Kinetics, despite Distinct T-Follicular Helper and Germinal Center B Cell Landscapes.

Authors:  Ashley N Nelson; Ria Goswami; Maria Dennis; Joshua Tu; Riley J Mangan; Pooja T Saha; Derek W Cain; Alan D Curtis; Xiaoying Shen; George M Shaw; Katharine Bar; Michael Hudgens; Justin Pollara; Kristina De Paris; Koen K A Van Rompay; Sallie R Permar
Journal:  J Virol       Date:  2019-07-17       Impact factor: 5.103

7.  Superiority in Rhesus Macaques of Targeting HIV-1 Env gp140 to CD40 versus LOX-1 in Combination with Replication-Competent NYVAC-KC for Induction of Env-Specific Antibody and T Cell Responses.

Authors:  Gerard Zurawski; Xiaoying Shen; Sandra Zurawski; Georgia D Tomaras; David C Montefiori; Mario Roederer; Guido Ferrari; Christine Lacabaratz; Peter Klucar; Zhiqing Wang; Kathryn E Foulds; Shing-Fen Kao; Xuesong Yu; Alicia Sato; Nicole L Yates; Celia LaBranche; Sherry Stanfield-Oakley; Karen Kibler; Bertram Jacobs; Andres Salazar; Steve Self; William Fulp; Raphael Gottardo; Lindsey Galmin; Deborah Weiss; Anthony Cristillo; Giuseppe Pantaleo; Yves Levy
Journal:  J Virol       Date:  2017-04-13       Impact factor: 5.103

8.  Rapid Development of gp120-Focused Neutralizing B Cell Responses during Acute Simian Immunodeficiency Virus Infection of African Green Monkeys.

Authors:  Joshua D Amos; Jonathon E Himes; Lawrence Armand; Thaddeus C Gurley; David R Martinez; Lisa Colvin; Krista Beck; R Glenn Overman; Hua-Xin Liao; M Anthony Moody; Sallie R Permar
Journal:  J Virol       Date:  2015-07-08       Impact factor: 5.103

9.  Virus-Like Particles Displaying Trimeric Simian Immunodeficiency Virus (SIV) Envelope gp160 Enhance the Breadth of DNA/Modified Vaccinia Virus Ankara SIV Vaccine-Induced Antibody Responses in Rhesus Macaques.

Authors:  Smita S Iyer; Sailaja Gangadhara; Blandine Victor; Xiaoying Shen; Xuemin Chen; Rafiq Nabi; Sudhir P Kasturi; Michael J Sabula; Celia C Labranche; Pradeep B J Reddy; Georgia D Tomaras; David C Montefiori; Bernard Moss; Paul Spearman; Bali Pulendran; Pamela A Kozlowski; Rama Rao Amara
Journal:  J Virol       Date:  2016-09-12       Impact factor: 5.103

10.  Combined HIV-1 Envelope Systemic and Mucosal Immunization of Lactating Rhesus Monkeys Induces a Robust Immunoglobulin A Isotype B Cell Response in Breast Milk.

Authors:  Cody S Nelson; Justin Pollara; Erika L Kunz; Thomas L Jeffries; Ryan Duffy; Charles Beck; Lisa Stamper; Minyue Wang; Xiaoying Shen; David J Pickup; Herman F Staats; Michael G Hudgens; Thomas B Kepler; David C Montefiori; M Anthony Moody; Georgia D Tomaras; Hua-Xin Liao; Barton F Haynes; Guido Ferrari; Genevieve G A Fouda; Sallie R Permar
Journal:  J Virol       Date:  2016-04-29       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.